PCYN Stock Overview
Manufactures and markets wound and skin care products primarily in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Procyon Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.20 |
| 52 Week High | US$0.34 |
| 52 Week Low | US$0.17 |
| Beta | -0.41 |
| 11 Month Change | 8.35% |
| 3 Month Change | -12.61% |
| 1 Year Change | 33.99% |
| 33 Year Change | -35.37% |
| 5 Year Change | -15.55% |
| Change since IPO | -86.60% |
Recent News & Updates
Recent updates
Shareholder Returns
| PCYN | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | 1.7% | 0.3% |
| 1Y | 34.0% | 21.4% | 31.1% |
Return vs Industry: PCYN exceeded the US Medical Equipment industry which returned 21.4% over the past year.
Return vs Market: PCYN exceeded the US Market which returned 31.1% over the past year.
Price Volatility
| PCYN volatility | |
|---|---|
| PCYN Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: PCYN's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine PCYN's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 20 | Justice Anderson | procyoncorp.com |
Procyon Corporation, together with its subsidiaries, manufactures and markets wound and skin care products primarily in the United States. It provides AMERIGEL, an advanced skin and wound care products, including hydrogel wound dressing, post op surgical kits, saline wound washes, and care and barrier lotions; HELIX3 Bioactive Collagen products, such as collagen powder, gel, and matrix; and calcium alginate dressing, foam dressing, amerx gauze dressing, hyrdocolloid dressing, as well as wound care kits, including calcium alginate, collagen matrix, collagen powder, foam, hydrogel, and rolled gauze wound care kits under the AMERX brand. The company also offers AMERIGEL hand sanitizer; EXTREMIT-EASE compression garment products; Advantagen, a surgical collagen powder that promotes wound closure and reduces the potential for surgical site infection; calcium alginate, foam, and gauze dressings; retention tapes; and helix collagen gel.
Procyon Corporation Fundamentals Summary
| PCYN fundamental statistics | |
|---|---|
| Market cap | US$1.64m |
| Earnings (TTM) | -US$312.96k |
| Revenue (TTM) | US$4.98m |
0.3x
P/S Ratio-5.2x
P/E RatioIs PCYN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PCYN income statement (TTM) | |
|---|---|
| Revenue | US$4.98m |
| Cost of Revenue | US$1.09m |
| Gross Profit | US$3.89m |
| Other Expenses | US$4.20m |
| Earnings | -US$312.96k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.038 |
| Gross Margin | 78.07% |
| Net Profit Margin | -6.28% |
| Debt/Equity Ratio | 0% |
How did PCYN perform over the long term?
See historical performance and comparison